-
1Academic Journal
Συγγραφείς: Grineva E.N., Tsoy U.A., Ryzhkova D.V.
Συνεισφορές: 0
Πηγή: Annals of the Russian academy of medical sciences; Vol 79, No 1 (2024); 77-86 ; Вестник Российской академии медицинских наук; Vol 79, No 1 (2024); 77-86 ; 2414-3545 ; 0869-6047 ; 10.15690/vramn.11
Θεματικοί όροι: neuroendocrine tumors, hypercortisolism, ectopic ACTH syndrome, functional imaging, нейроэндокринная опухоль, гиперкортицизм, эктопический АКТГ-синдром, функциональная визуализация
Περιγραφή αρχείου: application/pdf
Relation: https://vestnikramn.spr-journal.ru/jour/article/view/12677/1925; https://vestnikramn.spr-journal.ru/jour/article/view/12677/1896; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/12677/103163; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/12677/111986; https://vestnikramn.spr-journal.ru/jour/article/downloadSuppFile/12677/145559
-
2Academic Journal
Συγγραφείς: N. G. Mokrysheva, G. A. Melnichenko, L. V. Adamyan, E. A. Troshina, N. V. Molashenko, A. I. Sazonova, E V. Uvarova, R. M. Esayan, E. N. Andreeva, Z. A. Uzhegova, M. A. Kareva, N. Yu. Kalinchenko, B. M. Shifman, V. V. Fadeev, E. V. Biryukova, M. B. Antsiferov, L. A. Suplotova, T. P. Kiseleva, M. I. Yarmolinskaya, L. V. Suturina
Πηγή: Ожирение и метаболизм, Vol 18, Iss 3, Pp 345-382 (2021)
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, глюкокортикоиды, гиперкортицизм, Physiology, клинические рекомендации, QP1-981, дефицит 21-гидроксилазы, QD415-436, врожденная дисфункция коры надпочечников, Biochemistry, надпочечниковая гиперплазия, 3. Good health
-
3Academic Journal
Συγγραφείς: Lutsenko, L.А.
Πηγή: Mìžnarodnij Endokrinologìčnij Žurnal, Vol 14, Iss 2, Pp 205-210 (2018)
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; Том 14, № 2 (2018); 205-210
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 14, № 2 (2018); 205-210
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 14, № 2 (2018); 205-210Θεματικοί όροι: acromegalia, hypercorticism, 03 medical and health sciences, 0302 clinical medicine, glycated hemoglobin, diabetes mellitus, глікований гемоглобін, цукровий діабет, гіперкортицизм, акромегалія, RC648-665, Diseases of the endocrine glands. Clinical endocrinology, гликированный гемоглобин, сахарный диабет, гиперкортицизм, акромегалия, 3. Good health
Περιγραφή αρχείου: application/pdf
-
4Academic Journal
Συγγραφείς: N.O. Pertseva, T.V. Chursinova
Πηγή: Mìžnarodnij Endokrinologìčnij Žurnal, Vol 16, Iss 2, Pp 93-97 (2020)
Міжнародний ендокринологічний журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 2 (2020); 93-97
Международный эндокринологический журнал-Mìžnarodnij endokrinologìčnij žurnal; Том 16, № 2 (2020); 93-97
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY; Том 16, № 2 (2020); 93-97Θεματικοί όροι: болезнь Иценко — Кушинга, эндогенный гиперкортицизм, сахарный диабет, хвороба Іценка — Кушинга, ендогенний гіперкортицизм, цукровий діабет, endogenous hypercorticism, cushing disease, diabetes mellitus, RC648-665, Cushing disease, Diseases of the endocrine glands. Clinical endocrinology, 3. Good health
Περιγραφή αρχείου: application/pdf
-
5Academic Journal
Συγγραφείς: Shuprovich, A.
Πηγή: Clinical Endocrinology and Endocrine Surgery; № 3 (2020); 59-71
Clinical Endocrinology and Endocrine Surgery. Клиническая эндокринология и эндокринная хирургия; № 3 (2020); 59-71
Clinical Endocrinology and Endocrine Surgery. Клінічна ендокринологія та ендокринна хірургія; № 3 (2020); 59-71Θεματικοί όροι: 2. Zero hunger, type 2 diabetes mellitus, metabolic syndrome, functional hypercortisolism, cortisol, цукровий діабет 2 типу, метаболічний синдром, функціональний гиперкортицизм, кортизол, сахарный диабет 2 типа, метаболический синдром, функциональный гиперкортицизм, УДК 616.379-008.64.9:616.453-008.61:577.171.4, 3. Good health
Περιγραφή αρχείου: application/pdf
-
6Academic Journal
Πηγή: ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia». :35-47
Θεματικοί όροι: 0301 basic medicine, 0303 health sciences, адреноагонисты, скелетная мышца, iatrogenic hypercorticoidism, formoterol, dexamethasone, стероидная миопатия, 3. Good health, дексаметазон, формотерол, 03 medical and health sciences, steroid myopathy, ятрогенный гиперкортицизм, skeletal muscle, adrenergic agonists
Σύνδεσμος πρόσβασης: https://pfiet.ru/article/view/3324
https://pfiet.ru/article/download/3324/2407 -
7Academic Journal
Πηγή: ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia». :120-129
Θεματικοί όροι: 0301 basic medicine, 0303 health sciences, скелетная мышца, iatrogenic hypercorticoidism, dexamethasone, arginine, стероидная миопатия, аргинин, 3. Good health, дексаметазон, 03 medical and health sciences, steroid myopathy, ятрогенный гиперкортицизм, skeletal muscle
-
8Academic Journal
Συγγραφείς: Mokrysheva, N. G., Melnichenko, G. A., Adamyan, L. V., Troshina, E. A., Molashenko, N. V., Sazonova, A. I., Uvarova, E. V., Esayan, R. M., Andreeva, E. N., Uzhegova, Z. A., Kareva, M. A., Kalinchenko, N. Y., Shifman, B. M., Fadeev, V. V., Biryukova, E. V., Antsiferov, M. B., Suplotova, L. A., Kiseleva, T. P., Yarmolinskaya, M. I., Suturina, L. V., Мокрышева, Н. Г., Мельниченко, Г. А., Адамян, Л. В., Трошина, Е. А., Молашенко, Н. В., Сазонова, А. И., Уварова, Е. В., Есаян, Р. М., Андреева, Е. Н., Ужегова, Ж. А., Карева, М. А., Калинченко, Н. Ю., Шифман, Б. М., Фадеев, В. В., Бирюкова, Е. В., Анциферов, М. Б., Суплотова, Л. А., Киселева, Т. П., Ярмолинская, М. И., Сутурина, Л. В.
Θεματικοί όροι: ADRENAL HYPERPLASIA, CONGENITAL, 21-HYDROXYLASE DEFICIENCY, HYPERCORTICISM, GLUCOCORTICOIDS, CLINICAL PRACTICE GUIDELINES, НАДПОЧЕЧНИКОВАЯ ГИПЕРПЛАЗИЯ, ВРОЖДЕННАЯ ДИСФУНКЦИЯ КОРЫ НАДПОЧЕЧНИКОВ, ДЕФИЦИТ 21-ГИДРОКСИЛАЗЫ, ГИПЕРКОРТИЦИЗМ, ГЛЮКОКОРТИКОИДЫ, КЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИ
Περιγραφή αρχείου: application/pdf
Relation: Scopus; http://elib.usma.ru/handle/usma/7218
Διαθεσιμότητα: http://elib.usma.ru/handle/usma/7218
-
9Academic Journal
Πηγή: ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia». :104-111
Θεματικοί όροι: 0301 basic medicine, 0303 health sciences, скелетная мышца, adrenaline, гиперкортицизм, гидрокортизон, стероидная миопатия, 3. Good health, 03 medical and health sciences, steroid myopathy, hypercorticoidism, hydrocortisone, skeletal muscle, адреналин
Σύνδεσμος πρόσβασης: https://pfiet.ru/index.php/pfiet/article/view/595
-
10Academic Journal
Πηγή: Клінічна ендокринологія та ендокринна хірургія; № 4(56) (2016); 71-76
Clinical endocrinology and endocrine surgery; № 4(56) (2016); 71-76
Клиническая эндокринология и эндокринная хирургия; № 4(56) (2016); 71-76Θεματικοί όροι: акромегалия, сахарный диабет, инсулинорезистентность, субклинический гиперкортицизм, плюригормональная СТГ/АКТГ- продуцирующая аденома гипофиза, акромегалія, цукровий діабет, інсулінорезистентність, субклінічний гіперкортицизм, плюрігормональна СТГ/АКТГ- продукуюча аденома гіпофіза, acromegaly, diabetes mellitus, insulin resistance, subclinical Cushing syndrome, plurihormonal GH/AСTH-producing pituitary adenoma, УДК 616.433, 3. Good health
Περιγραφή αρχείου: application/pdf
-
11Academic Journal
Συγγραφείς: Kiseleva, T. P., Chzhen, T. R., Torosyan, M. R., Киселева, Т. П., Чжен, Т. Р., Торосян, М. Р.
Θεματικοί όροι: BILATERAL ADRENALECTOMY, PRIMARY BILATERAL MACRONODULAR ADRENAL HYPERPLASIA (PBMAH), HYPERCORTICOLISM, ДВУСТОРОННЯЯ АДРЕНАЛЭКТОМИЯ, ПЕРВИЧНАЯ ДВУСТОРОННЯЯ МАКРОУЗЛОВАЯ ГИПЕРПЛАЗИЯ НАДПОЧЕЧНИКОВ (ПДМГН), ГИПЕРКОРТИЦИЗМ
Περιγραφή αρχείου: application/pdf
Relation: Уральский медицинский журнал. 2018. Т. 160, № 5.; http://elib.usma.ru/handle/usma/12670
Διαθεσιμότητα: http://elib.usma.ru/handle/usma/12670
-
12Academic Journal
Συγγραφείς: Galina A. Melnichenko, L Ya Rozhinskaya, Zh E Belaya, Ivan Ivanovich Dedov, N V Dragunova, L K Dzeranova
Πηγή: Остеопороз и остеопатии, Vol 16, Iss 1, Pp 7-13 (2013)
Θεματικοί όροι: Osteopathy, 03 medical and health sciences, 0302 clinical medicine, эндогенный гиперкортицизм, RZ301-397.5, низкотравматичные переломы, уровень кортизола как предиктор переломов, 3. Good health
-
13Academic Journal
Συγγραφείς: G S Kolesnikova, S A Butrova, Zh E Belaya, Ekaterina Troshina, L Ya Rozhinskaya, A V Il'in, Galina A. Melnichenko, N V Dragunova
Πηγή: Остеопороз и остеопатии, Vol 14, Iss 2, Pp 7-10 (2011)
Θεματικοί όροι: остеокальцин, Osteopathy, 0301 basic medicine, 03 medical and health sciences, 0302 clinical medicine, эндогенный гиперкортицизм, ожирение, RZ301-397.5, маркёры костного обмена, остеопороз
-
14Academic Journal
Συγγραφείς: Kadzharian, V. G., Soloviuk, O. O.
Πηγή: Zaporožskij Medicinskij Žurnal, Iss 2, Pp 253-258 (2018)
Zaporozhye Medical Journal; Vol. 20 No. 2 (2018)
Запорожский медицинский журнал; Том 20 № 2 (2018)
Запорізький медичний журнал; Том 20 № 2 (2018)Θεματικοί όροι: хвороба Кушинга, adrenocortical hyperfunction, гиперкортицизм, лікування, therapeutics, Medicine, hypophysieal acth hypersecration, лечение, пасиреотид, болезнь Кушинга, 3. Good health, гіперкортицизм
Περιγραφή αρχείου: application/pdf
Σύνδεσμος πρόσβασης: http://zmj.zsmu.edu.ua/article/download/125354/124639
https://doaj.org/article/fdd01e41e4864e08908ac658357cd68c
https://core.ac.uk/display/156973669
http://zmj.zsmu.edu.ua/article/download/125354/124639
http://zmj.zsmu.edu.ua/article/view/125354
http://zmj.zsmu.edu.ua/article/view/125354 -
15Academic Journal
Θεματικοί όροι: 2. Zero hunger, hypercorticolism, Двусторонняя адреналэктомия, гиперкортицизм, primary bilateral macronodular adrenal hyperplasia (PBMAH), первичная двусторонняя макроузловая гиперплазия надпочечников (ПДМГН), Bilateral adrenalectomy, 3. Good health
Σύνδεσμος πρόσβασης: https://umj.usma.ru/jour/article/view/182
https://umj.usma.ru/jour/article/download/182/182 -
16Academic Journal
Συγγραφείς: Komerdus I.V., Dreval' A.V., Chekanova A.V., Akulkina L.A.
Πηγή: Almanac of Clinical Medicine; Vol 44, No 4 (2016); 430-438 ; Альманах клинической медицины; Vol 44, No 4 (2016); 430-438 ; 2587-9294 ; 2072-0505 ; 10.18786/2072-0505-2016-44-4
Θεματικοί όροι: hypercorticism, hypercortisolism, Cushing's disease, clinical signs, symptoms, complaints, гиперкортицизм, гиперкортизолизм, болезнь Иценко – Кушинга, клинические проявления, симптомы, жалобы
Περιγραφή αρχείου: application/pdf
Relation: https://almclinmed.ru/jour/article/view/432/398; https://almclinmed.ru/jour/article/downloadSuppFile/432/1091; https://almclinmed.ru/jour/article/downloadSuppFile/432/1092; https://almclinmed.ru/jour/article/downloadSuppFile/432/1093; https://almclinmed.ru/jour/article/downloadSuppFile/432/1094; https://almclinmed.ru/jour/article/downloadSuppFile/432/1095; https://almclinmed.ru/jour/article/view/432
-
17Academic Journal
Συγγραφείς: ТРЕТЯК О.Е., ЩЕКАТУРОВА Л.В., КИДАЛОВА Г.А., КОГУТ Д.Г.
Θεματικοί όροι: АКРОМЕГАЛИЯ,САХАРНЫЙ ДИАБЕТ,ИНСУЛИНОРЕЗИСТЕНТНОСТЬ,СУБКЛИНИЧЕСКИЙ ГИПЕРКОРТИЦИЗМ,ПЛЮРИГОРМОНАЛЬНАЯ СТГ/АКТГПРОДУЦИРУЮЩАЯ АДЕНОМА ГИПОФИЗА
Περιγραφή αρχείου: text/html
-
18Academic Journal
Συγγραφείς: КВАЧЕНЮК А.Н., ЛУЦЕНКО Л.А.
Θεματικοί όροι: гиперкортицизм, ожирение, сахарный диабет, артериальная гипертензия, кортизол слюны
Περιγραφή αρχείου: text/html
-
19Academic Journal
-
20Academic Journal
Συγγραφείς: G. A. Melnichenko, I. S. Stilidi, . ., B. Ya. Alexeev, D. G. Beltsevich, A. O. Raykhman, N. S. Kuznetsov, N. V. Zhukov, V. Yu. Bokhyan, Г. А. Мельниченко, И. С. Стилиди, В. А. Горбунова, Б. Я. Алексеев, Д. Г. Бельцевич, А. О. Райхман, Н. С. Кузнецов, Н. В. Жуков, В. Ю. Бохян
Πηγή: Medical Herald of the South of Russia; № 1 (2015); 4-20 ; Медицинский вестник Юга России; № 1 (2015); 4-20 ; 2618-7876 ; 2219-8075 ; 10.21886/2219-8075-2015-1
Θεματικοί όροι: опухоли надпочечника, адренокортикальный рак, рак коры надпочечника, феохромоцитома, параганглиома, гиперкортицизм, митотан
Περιγραφή αρχείου: application/pdf
Relation: https://www.medicalherald.ru/jour/article/view/184/185; BerrutiA, BaudinE, GelderblomHet al. Adrenal cancer: ESMO (European Society for Medical Oncology) Clinical Practice Guidelines for diagnosis, treatment and follow-up on behalf of the ESMO Guidelines Working Group. Annals of Oncology. ;23:131-138.; NCCN Clinical Practice Guidelines in Oncology, Neuroendocrine tumor, Version 1.2014.; Schteingart DE, Doherty GM, Gauger PG et al. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12:667.; Langer P, Cupisti K, Bartsch DK et al. Adrenal involvement in multiple endocrine neoplasia type 1.World J Surg.2002;26:891- 896.; Gicquel C, Le Bouc Y. Molecular markers for malignancy in adrenocortical tumors. Horm Res.1997;47:269-272.; БельцевичДГ, КузнецовНС, СолдатоваТВ, ВанушкоВЭ. Инциденталоманадпочечников.Эндокриннаяхирургия. 2009.№1.; Bovio S, Cataldi A, Reimondo G, et al. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006;29:298-302.; Young W.F.,Jr. Th e Incidentally Discovered Adrenal Mass. N Engl J Med. 2007;356:601-10.; Cawood T J, Hunt P J, O’Shea D, Cole D, Soule S. Recommended evaluation of adrenal incidentalomas is costly, has high falsepositive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Literature review. Eur J Endocrinol. 2009;161:513-527.; Libe R, Dall’Asta C, Barbetta L et al. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol. 2002;147:489–494.; Terzolo M, Reimondo G, Bovio S, Angeli ASubclinical Cushing’s syndrome. Pituitary. 2004;7:217-223.; Kirkby-Bott J, Brunaud L, Mathonet M, Hamoir E, Kraimps JL, Tresallet C, Amar L, Rault A, Henry JF, Carnaille B. Ectopic hormone-secreting pheochromocytoma: a francophone observational study. World J Surg. 2012;36(6):1382-1388.; Li XG, Zhang DX, Li X, Cui XG, Xu DF, Li Y, Gao Y, Yin L, Ren JZ Adrenocorticotropic hormone-producing pheochromocytoma: a case report and review of the literature. Chin Med J (Engl). 2012;125(6):1193-1196.; Cohade C, Broussaud S, Louiset E, Bennet A, Huyghe E, Caron P. Ectopic Cushing’s syndrome due to a pheochromocytoma: a new case in the post-partum and review of literature.Gynecol Endocrinol. 2009;25(9):624-627.; Gardet V et al.Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma. J Hypertens.2001;19:1029-1035.; NiemanLK, BillerBMK, FindlingJWet al. Th e diagnosis of Cushing’s syndrome:an endocrine society clinical practice guideline Journal of Clin Endoc & Met. 2008;93(5):1526-1540.; Newell-Price J, Trainer P, Besser M, Grossman A Th e diagnosis and diff erential diagnosis of Cushing’s syndrome and pseudo-Cushing’s states. Endocr Rev 1998;19:647-672.; Pecori Giraldi F, Ambrogio AG, De Martin Met al. Specifi city of fi rst-line tests for the diagnosis of Cushing’s syndrome: assessment in a large series. J Clin Endocrinol Metab.2007;92:4123-4129.; Tsagarakis S, Vassiliadi D, Th alassinos N. Endogenous subclinical hypercortisolism: diagnostic uncertainties and clinical implications. J Endocrinol Invest.2006;29:471-482.; Mitchell IC, Auchus RJ, Juneja Ket al. “Subclinical Cushing’s syndrome” is not subclinical: improvement aft er adrenalectomy in 9 patients. Surgery 2007;142:900-905.; Mitchell IC, Auchus RJ, Juneja K et al. “Subclinical Cushing’s syndrome” is not subclinical: improvement aft er adrenalectomy in 9 patients. Surgery 2007;142:900-905.; Barzon L, Fallo F, Sonino N, Boscaro M. Development of overt Cushing’s syndrome in patients with adrenal incidentaloma. Eur J Endocrinol. 2002;146:61-66.; Reincke M Subclinical Cushing’s syndrome. Endocrinol Metab Clin North Am. 2000;29:43-56.; Pacak K Preoperative management of the pheochromocytoma patient. J Clin Endocrinol Metab 2007;92:4069-4079.; Williams DT, Dann S, Wheeler MH. Phaeochromocytoma – views on current management. Eur J Surg Oncol.2003;29:483-490.; Kinney MA et al. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth.2002;16:359-369.; Pacak K et al.Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern; Med.2001;134:315-329.; Дедов ИИ, Бельцевич ДГ, Кузнецов НС, Мельниченко ГА. Феохромоцитома. Москва, РФ: Практ. медицина; 2005;47-70.; An Endocrine Society Clinical Practice Guidelines. Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism. J Clin Endocrinol Metab. 2008;93(9):3266-3281.; Трошина ЕА, Бельцевич ДГ, Молашенко НВ. Диагностика и дифференциальная диагностика первичного гиперальдостеронизма. Клиническаямедицина. 2009;5:15-20.; Mantero F, Terzolo M, Arnaldi G, et al. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab.2000;85(2):637-644.; Angeli A, Osella G, Ali A, Terzolo M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res. 1997;47:279-283.; Metser U,MillerE, LermanH et al.18F-FDG PET/CT in the Evaluation of Adrenal Masses. J Nucl Med. 2006;47(1):32-37.; M. Blake, P. Prakash, C.Cronin. PET/CT for Adrenal Assessment Am J Roentgenology. 2010;195(2):195.; Mackie GC, Shulkin BL, Ribeiro RC, et al. Use of [18F] fl uorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. 2006;91:2665.; Leboulleux S, Dromain C, Bonniaud G et al. Diagnostic and prognostic value of 18-fl uorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol; Metab. 2006;91:920.; Deandreis D, Leboulleux S, Caramella C, et al. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011;2:354.; Harisinghani MG, Maher MM, Hahn PF et al. Predictive value of benign percutaneous adrenal biopsies in oncology patients. Clin Radiol. 2002;57:898-901.; Arellano RS, Harisinghani MG, Gervais DA et al Imageguided percutaneous biopsy of the adrenal gland: review of indications, technique, and complications. Curr Probl Diagn Radiol. 2003;32:3-10.; Welch TJ, Sheedy PF II, Stephens DH et al. Percutaneous adrenal biopsy: review of a 10-year experience. Radiology. 1994;193:341-344.; Casola G, Nicolet V, van Sonnenberg E et al. Unsuspected pheochromocytoma: risk of blood-pressure alterations during percutaneous adrenal biopsy. Radiology. 1986;159:733-735.; McCorkell SJ, Niles NL. Fine-needle aspiration of catecholamineproducing adrenal masses: a possibly fatal mistake. Am J Roentgenol. 1985;145:113-114.; Pacak K, Eisenhofer G, Ahlman H et al.Pheochromocytoma: recommendations for clinical practice from the First International Symposium. Nat Clin Pract Endocrinol Metab.2007;3:92-102.; SaegerW, FassnachtM, ChitaR. High Diagnostic Accuracy of Adrenal CoreBiopsy: Results of the German and Austrian Adrenal Network Multicenter Trial in 220 Consecutive Patients. Human pathology. 2003;34(2):180-186.; Dackiw AP, Lee JE, Gagel RF, Evans DB. Adrenal cortical carcinoma. World J Surg.2001;25:914-926; Ng L, Libertino JM. Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol.2003;169:5-11.; Miller BS, Gauger PG, Hammer GD et al. Proposal for modifi cation of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbecks Arch Surg.2010;395:955.; Fassnacht M, Johanssen S, Quinkler M et al. Limited prognostic value of the 2004 International Union Against Cancer staging classifi cation for adrenocortical carcinoma: proposal for a Revised TNM Classifi cation. Cancer 2009;115:243.; Wangberg B, Khorram-Manesh A, Jansson S, et al. Th e longterm survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Endocr Relat Cancer. 2010;17:265.; Allolio B, Fassnacht M. Clinical review: Adrenocortical carcinoma: clinical update. JClinEndocrinolMetab. 2006;91:2027.; Филимонюк А.В., Харченко Н.В., Леонов Б.И., Смирнова Е.А., АнтоновА.К., Смелкова Н.И. Непосредственные и отдаленные результаты хирургического лечения больных адренокортикальным раком. Вестник новых медицинских; технологий (электронное издание).2013;1[Электронный ресурс].; Reibetanz J, Jurowich C, Erdogan I et al. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Ann Surg. 2012;255:363.; Gaujoux S, Brennan MF. Recommendation for standardized surgical management of primary adrenocortical carcinoma. Surgery. 2012 152(1):123-32.; Porpiglia F, Miller BS, Manfredi M et al. A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma. Horm Cancer. 2011;2:372.; Brix D, Allolio B, Fenske W et al. Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients. Eur Urol. 2010;58:609.; Donatini G, Caiazzo R, Do Cao Ch et al. Long-Term Survival Aft er Adrenalectomy for Stage I/II Adrenocortical Carcinoma (ACC): A Retrospective Comparative Cohort Study of Laparoscopic Versus Open Approach. Ann Surg Oncol. 2014;21:284-291.; McCauley LR, Nguyen MM. Laparoscopic radical adrenalectomy for cancer: long-term outcomes. Curr Opin Urol. 2008;18:134.; Gonzalez RJ, Shapiro S, Sarlis N et al. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note. Surgery. ;138(6):1078.; Miller BS, Gauger PG, Hammer GD, Doherty GM. Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more oft en aft er laparoscopic adrenalectomy than aft er open adrenalectomy. Surgery. 2012;152:1150-1157.; Leboulleux S, Deandreis D, Ghuzlan A Al et al. Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal сarcinomatosis? Eur J Endocrinol. 2010;162:1147-1153; Schulick RD, Brennan MF. Long-term survival aft er complete resection and repeat resection in patients with adrenocortical carcinoma. Ann Surg Oncol. 1999;6(8):719-726.; Icard P, Chapuis Y, Andreassian B, et al. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery. 1992;112(6):972-979.; Bellantone R, Ferrante A, Boscherini M, et al.: Role of reoperation in recurrence of adrenal cortical carcinoma: results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma. Surgery. 1997,122:1212-1218.; Porpiglia F, Fiori C, Scarpa RM et al. Th e role of surgery in the management of recurrent adrenocortical carcinoma: results of a retrospective study. Eur Urol Suppl. 2009;8(4):305.; Weiss LM. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol. 1984;8(3):163-169.; Lau SK, Weiss LM. Th e Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol. 2009;40(6):757-768.; van Slooten H, Schaberg A, Smeenk D, Moolenar AJ. Morphologic characteristics of benign and malignant adrenocortical tumors. Cancer. 1985 Feb 15;55(4):766-773.; Blanes Aet al. Histologic criteria for adrenocortical proliferative lesions: value of mitotic fi gure variability. Am J Clin Pathol. 2007;127(3):398-408.; Филиппова ОВ. Адренокортикальный рак: клинические проявления и морфологическая диагностика / Филиппова О.В., Хмельницкая Н.М. // Медицинский альманах. 2011;5:113-116.; Hahner S, Fassnacht M. Mitotane for adrenocortical carcinoma treatment. Curr Opin Investig Drugs.2005;6:386-394.; Schteingart DE. Conventional and novel strategies in the treatment of adrenocortical cancer. Braz J Med Biol Res.2000;33:1197-1200.; Hague RV, May W, Cullen DR. Hepatic microsomal enzyme induction and adrenal crisis due to o,p_DDD therapy for metastatic adrenocortical carcinoma. Clin Endocrinol (Oxf).1989;31:51-57.; Dickstein G. Is there a role of low dose of mitotane as adjuvant therapy in adrenocortical carcinoma? J Clin Endocrinol Metab.1999;84:1488-1489.; Vassilopoulou-Sellin R, Guinee VF, Klein MJ, et al. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer. Cancer.1993;71:3119-3123.; Terzolo M, Angeli A, Fassnacht M Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 2007;356(23):2372.; Clinical trials gov. identifi er NCT00777244, start 2008, update 2013.; Lubitz JA, Freeman L, Okun R Mitotane use in inoperable adrenalcortical carcinoma. JAMA.1973;223:1109-1112.; van Slooten H, Moolenaar AJ, van Seters AP, Smeenk D. Th e treatment of adrenocortical carcinoma with o,p_-DDD; prognostic implications of serum level monitoring. Eur J Cancer Clin Oncol.1984;20:47-53.; Haak HR, Hermans J, van de Velde CJ et al. Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. Br J Cancer.1994;69:947-951.; Baudin E, Pellegriti G, Bonnay M et al. Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p_DDD) levels on the treatment of patients with adrenocortical carcinoma. Cancer.2001;92:1385-1392.; Heilmann P, Wagner P, Nawroth PP, Ziegler R[Th erapy of the adrenocortical carcinoma with Lysodren (o,p’-DDD). Th erapeutic management by monitoring o,p_-DDD blood levels]. Med Klin.2001;96:371-377.; Becker D, Schumacher OP. o,p’DDD therapy in invasive adrenocortical carcinoma. Ann Intern Med.1975;82:677-679.; Boven E, Vermorken JB, van Slooten H, PinedoHM. Complete response of metastasized adrenal cortical carcinoma with o,p_- DDD. Case report and literature review. Cancer.1984;53:26-29.; Krzisnik C, Petric G, Jereb B. Complete response of metastatic adrenal cortical carcinoma to o,p_-DDD in a child. Pediatr Hematol Oncol.1988;5:65-69.; Lim MC, Tan YO, Chong PY, Cheah JS. Treatment of adrenal cortical carcinoma with mitotane: outcome and complications. Ann Acad Med Singapore.1990.; Decker RA, Kuehner ME. Adrenocortical carcinoma. Am Surg.1991;57:502-513.; Remond S, Bardet S, Charbonnel B. Complete and lasting remission of a metastatic malignant adrenocortical carcinoma under treatment with OP- _DDD alone. Presse Med.1992;21:865.; Ilias I, Alevizaki M, Philippou G, Anastasiou E, Souvatzoglou A. Sustained remission of metastatic adrenal carcinoma during long-term administration of low-dose mitotane. J Endocrinol Invest.2001;24:532-535.; Allolio B, Hahner S, Weismann D, Fassnacht M. Management of adrenocortical carcinoma. Clin Endocrinol (Oxf).2004;60:273- 287. 19:540-544.; Fassnacht M, Libe R, Kroiss M, Allolio B. Adrenocortical carcinoma: a clinician’s update. Nat Rev Endocrinol. 2011;7:323.; Cordon-Cardo C, O’Brien JP, Boccia J et al. Expression of the multidrug resistance gene product (P-glycoprotein); in human normal and tumor tissues. J Histochem Cytochem.1990;38:1277-1287.; Flynn SD, Murren JR, Kirby WM et al.P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma.; Surgery.1992;112:981-986.; Goldstein LJ, Galski H, Fojo A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst.1989;81:116-124.; Fridborg H, Larsson R, Juhlin C, Rastad J, Akerstrom G, Backlin K, Nygren PP-glycoprotein expression and activity of resistance modifying agents in primary cultures of human renal and adrenocortical carcinoma cells. An-ticancer Res.1994;14:1009-1016.; Haak HR, van Seters AP, Moolenaar AJ, Fleuren GJ Expression of P-glycoprotein in relation to clinical manifestation, treatment and prognosis of adrenocortical cancer. Eur J Cancer.1993;29A:1036-1038.; Fassnacht M, Terzolo M, Allolio B et al. Combination chemotherapy in advanced adrenocortical carcinoma. FIRMACT Study GroupN Engl J Med. 2012;366(23):2189.; Martin Fassnacht, Matthias Kroiss, and Bruno Allolio. Update in Adrenocortical Carcinoma. J Clin Endocrinol Metab. 2013, 98(12):4551-4564.; Icard P, Goudet P, Charpenay C. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg.2001;25:891-897.; Crucitti F, Bellantone R, Ferrante A, et al. Th e Italian Registry for Adrenal Cortical Carcinoma: analysis of a multiinstitutional series of 129 patients. Th e ACC Italian Registry Study Group. Surgery.1996;119:161-170.; Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992;112:963-970; discussion, 970-971.; Soreide JA, Brabrand K, Th oresen SO. Adrenal cortical carcinoma in Norway, 1970–1984. World J Surg.1992;16:663- 667; discussion, 668.; Vassilopoulou-Sellin R, Schultz PN. Adrenocortical carcinoma. Clinical outcome at the end of the 20th century. Cancer.2001;92:1113-1121.; https://www.medicalherald.ru/jour/article/view/184
